Published in Hospital Law Weekly, February 22nd, 2007
The next-generation Ultra System, which was approved by the U.S. Food and Drug Administration (FDA) in December for blood clot removal (thrombectomy), was successfully used by physicians at the Mercy Heart & Vascular Center in multiple thrombectomy procedures over the past two weeks.
"AngioJet thrombectomy has been used in our labs for several years now and this newest generation greatly improves the ease and time to set up in emergent cases. The AngioJet System continues to deliver the most...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.